BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19171337)

  • 1. Hepatic steatosis in young lean insulin resistant women with polycystic ovary syndrome.
    Markou A; Androulakis II; Mourmouris C; Tsikkini A; Samara C; Sougioultzis S; Piaditis G; Kaltsas G
    Fertil Steril; 2010 Mar; 93(4):1220-6. PubMed ID: 19171337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of insulin resistance in lean women with polycystic ovary syndrome.
    Morciano A; Romani F; Sagnella F; Scarinci E; Palla C; Moro F; Tropea A; Policola C; Della Casa S; Guido M; Lanzone A; Apa R
    Fertil Steril; 2014 Jul; 102(1):250-256.e3. PubMed ID: 24825420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diverse impacts of aging on insulin resistance in lean and obese women with polycystic ovary syndrome: evidence from 1345 women with the syndrome.
    Livadas S; Kollias A; Panidis D; Diamanti-Kandarakis E
    Eur J Endocrinol; 2014 Sep; 171(3):301-9. PubMed ID: 25053727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome.
    Vassilatou E; Lafoyianni S; Vryonidou A; Ioannidis D; Kosma L; Katsoulis K; Papavassiliou E; Tzavara I
    Hum Reprod; 2010 Jan; 25(1):212-20. PubMed ID: 19887498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic fatty liver disease in women with polycystic ovary syndrome.
    Cerda C; Pérez-Ayuso RM; Riquelme A; Soza A; Villaseca P; Sir-Petermann T; Espinoza M; Pizarro M; Solis N; Miquel JF; Arrese M
    J Hepatol; 2007 Sep; 47(3):412-7. PubMed ID: 17560682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance.
    Tan S; Hahn S; Benson S; Dietz T; Lahner H; Moeller LC; Schmidt M; Elsenbruch S; Kimmig R; Mann K; Janssen OE
    Eur J Endocrinol; 2007 Nov; 157(5):669-76. PubMed ID: 17984248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity.
    Baillargeon JP; Carpentier A
    Fertil Steril; 2007 Oct; 88(4):886-93. PubMed ID: 17559844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular risk in young women with polycystic ovary and polycystic ovary syndrome.
    Battaglia C; Mancini F; Cianciosi A; Busacchi P; Facchinetti F; Marchesini GR; Marzocchi R; de Aloysio D
    Obstet Gynecol; 2008 Feb; 111(2 Pt 1):385-95. PubMed ID: 18238977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome.
    Carmina E; Lobo RA
    Fertil Steril; 2004 Sep; 82(3):661-5. PubMed ID: 15374711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: a prospective controlled study.
    Dalamaga M; Papadavid E; Basios G; Vaggopoulos V; Rigopoulos D; Kassanos D; Trakakis E
    J Am Acad Dermatol; 2013 Dec; 69(6):922-30. PubMed ID: 24120563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome.
    Gambarin-Gelwan M; Kinkhabwala SV; Schiano TD; Bodian C; Yeh HC; Futterweit W
    Clin Gastroenterol Hepatol; 2007 Apr; 5(4):496-501. PubMed ID: 17287148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
    Ardawi MS; Rouzi AA
    Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
    Graff SK; Mário FM; Alves BC; Spritzer PM
    Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal metabolic rate is decreased in women with polycystic ovary syndrome and biochemical hyperandrogenemia and is associated with insulin resistance.
    Georgopoulos NA; Saltamavros AD; Vervita V; Karkoulias K; Adonakis G; Decavalas G; Kourounis G; Markou KB; Kyriazopoulou V
    Fertil Steril; 2009 Jul; 92(1):250-5. PubMed ID: 18678372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance and its relationship with high molecular weight adiponectin in adolescents with polycystic ovary syndrome and a maternal history of polycystic ovary syndrome.
    Cankaya S; Demir B; Aksakal SE; Dilbaz B; Demirtas C; Goktolga U
    Fertil Steril; 2014 Sep; 102(3):826-30. PubMed ID: 24973036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.
    Brzozowska MM; Ostapowicz G; Weltman MD
    J Gastroenterol Hepatol; 2009 Feb; 24(2):243-7. PubMed ID: 19215335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variation in exon 17 of INSR is associated with insulin resistance and hyperandrogenemia among lean Indian women with polycystic ovary syndrome.
    Mukherjee S; Shaikh N; Khavale S; Shinde G; Meherji P; Shah N; Maitra A
    Eur J Endocrinol; 2009 May; 160(5):855-62. PubMed ID: 19211708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased prevalence of polycystic ovary syndrome in premenopausal women with nonalcoholic fatty liver disease.
    Vassilatou E; Vassiliadi DA; Salambasis K; Lazaridou H; Koutsomitopoulos N; Kelekis N; Kassanos D; Hadjidakis D; Dimitriadis G
    Eur J Endocrinol; 2015 Dec; 173(6):739-47. PubMed ID: 26340970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evaluation of endothelial function with flow-mediated dilatation and carotid intima media thickness in young nonobese polycystic ovary syndrome patients; existence of insulin resistance alone may not represent an adequate condition for deterioration of endothelial function.
    Arikan S; Akay H; Bahceci M; Tuzcu A; Gokalp D
    Fertil Steril; 2009 Feb; 91(2):450-5. PubMed ID: 18501898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of resolving method of Chinese medicine on the lipid metabolism in polycystic ovary syndrome accompanied with non-alcoholic fatty liver disease].
    Chen Y; Wang XJ; Jin HL; Jin L
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jun; 33(6):751-6. PubMed ID: 23980352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.